{
  "id": "c4f77f515254f28e254d66d05a4be09e833c8f4e",
  "title": "Keep EU drug price agreements confidential or risk market disruption [Advocacy Lab]",
  "summary_full": "US benchmarking of drug prices against foreign markets could have unintended consequences, says Czech health economist Tomáš Doležal, he urges EU to protect pricing confidentiality",
  "summary_public": "US benchmarking of drug prices against foreign markets could have unintended consequences, says Czech health economist Tomáš Doležal, he urges EU to protect pricing confidentiality",
  "url": "https://www.euractiv.com/news/keep-eu-drug-price-agreements-confidential-or-risk-market-disruption/",
  "published_at": "2026-02-26T23:05:06+00:00",
  "source": "Euractiv",
  "language": "en",
  "countries_detected": [
    "CZ"
  ],
  "countries_scored": [
    "CZ"
  ],
  "llm_version": "v3-eu",
  "llm_perspective": "EU",
  "llm_attempted_at": "2026-03-01T09:45:48+00:00",
  "sentiment_by_country": {
    "CZ": {
      "label": "negative",
      "confidence": 0.7,
      "evidence": "risk market disruption [Advocacy Lab]"
    }
  },
  "processed_at": "2026-03-01T09:45:48+00:00"
}